1. Home
  2. AWRE vs GDTC Comparison

AWRE vs GDTC Comparison

Compare AWRE & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aware Inc.

AWRE

Aware Inc.

N/A

Current Price

$1.99

Market Cap

44.5M

Sector

Technology

ML Signal

N/A

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$1.43

Market Cap

24.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AWRE
GDTC
Founded
1986
2018
Country
United States
Singapore
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.5M
24.8M
IPO Year
1996
2023

Fundamental Metrics

Financial Performance
Metric
AWRE
GDTC
Price
$1.99
$1.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
30.9K
37.7K
Earning Date
10-29-2025
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,428,000.00
$573,193.00
Revenue This Year
N/A
$5.37
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.72
63.03
52 Week Low
$1.37
$1.38
52 Week High
$2.95
$4.05

Technical Indicators

Market Signals
Indicator
AWRE
GDTC
Relative Strength Index (RSI) 36.04 35.27
Support Level $1.99 $1.49
Resistance Level $2.17 $1.63
Average True Range (ATR) 0.09 0.12
MACD -0.00 -0.00
Stochastic Oscillator 9.62 10.64

Price Performance

Historical Comparison
AWRE
GDTC

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: